VANGUARD GROUP INC 13D and 13G filings for IDEXX Laboratories, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-12 3:48 pm Unchanged | 2024-09-30 | 13G | IDEXX Laboratories, Inc. IDXX | VANGUARD GROUP INC | 9,703,237 11.780% | 0 (Unchanged) | Filing |
| 2024-11-04 11:47 am Purchase | 2024-09-30 | 13G | IDEXX Laboratories, Inc. IDXX | VANGUARD GROUP INC | 9,703,237 11.780% | 1,325,570 (+15.82%) | Filing |
| 2024-02-13 5:06 pm Purchase | 2023-12-29 | 13G | IDEXX Laboratories, Inc. IDXX | VANGUARD GROUP INC | 8,377,667 10.090% | 45,970 (+0.55%) | Filing |
| 2023-12-08 4:16 pm Purchase | 2023-11-30 | 13G | IDEXX Laboratories, Inc. IDXX | VANGUARD GROUP INC | 8,331,697 10.030% | 199,218 (+2.45%) | Filing |
| 2023-02-09 11:22 am Purchase | 2022-12-30 | 13G | IDEXX Laboratories, Inc. IDXX | VANGUARD GROUP INC | 8,132,479 9.820% | 209,013 (+2.64%) | Filing |
| 2022-02-10 08:17 am Sale | 2021-12-31 | 13G | IDEXX Laboratories, Inc. IDXX | VANGUARD GROUP INC | 7,923,466 9.340% | -1,181,793 (-12.98%) | Filing |
| 2021-02-10 11:03 am Sale | 2020-12-31 | 13G | IDEXX Laboratories, Inc. IDXX | VANGUARD GROUP INC | 9,105,259 10.670% | -344,559 (-3.65%) | Filing |